Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Perspective Therapeutics(CATX) Newsfilter·2025-01-13 13:00
Anticipates multiple clinical updates in the next 12-18 months, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of one new asset based on its next generation targeted radiopharmaceutical technology platformFour additional new assets being evaluated for IND development, to be guided by first-in-human imagesMaking progress on plans to expand manufacturing capabilities by improving efficiencies of existing facilities and building out recently acquired sites, w ...